The U.S. Department of Health and Human Services (HHS) on Tuesday said it is delivering $613,790,442 in new funding to New Jersey to support testing for COVID-19.
In total, $10.25 billion in funding is being provided by The Centers for Disease Control and Prevention (CDC) to states, territories and local jurisdictions through its existing Epidemiology and Laboratory Capacity for Prevention and Control of Emerging Infectious Diseases (ELC) cooperative agreement.
This funding from the Paycheck Protection Program and Health Care Enhancement Act will provide critical support to develop, purchase, administer, process, and analyze COVID-19 tests, conduct surveillance, trace contacts, and related activities.
“Readily accessible testing is a critical component of a four-pronged public health strategy – including rigorous contact tracing, isolation of confirmed cases, and quarantine,” said CDC Director Robert Redfield. “As communities move toward a blended mitigation and containment strategy, I encourage all Americans to continue to embrace powerful public health measures – social distancing, hand washing and face coverings. We are not defenseless in the battle against this pandemic.”
Each governor or designee of each state, locality, or territory receiving funds should submit to HHS its plan for COVID-19 testing, including goals for the remainder of calendar year 2020, to include:
- Number of tests needed, month-by-month to include diagnostic, serological, and other tests, as appropriate;
- Month-by-month estimates of laboratory and testing capacity, including related to workforce, equipment and supplies, and available tests; and
- Description of how the resources will be used for testing, including easing any COVID-19 community mitigation policies.
Jurisdictions will use the funding they receive to meet the testing goals laid out in their COVID-19 testing plans, including purchasing supplies (such as test kits and other testing supplies, as necessary).
The list of funding recipients is available here.